
Isoray ISR
Geschäftsbericht 2025
hinzugefügt 16.03.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NYSE AMERICAN |
Anteile |
73.8 M |
Marktkapitalisierung |
$ 108 M |
EBITDA (LTM) |
$ -41.2 M |
P/E (LTM) |
- |
P/S (LTM) |
13.42 |
EPS (LTM) |
-1.03 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 80.83 | 1.1 % | $ 40.4 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.28 | 2.8 % | $ 24.9 M | Nasdaq Capital Market | ||
|
iRhythm Technologies
IRTC
|
$ 124.53 | 1.05 % | $ 3.99 B | Nasdaq Global Select Market,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 62.09 | 2.73 % | $ 3.12 B | NYSE,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.26 | -0.93 % | $ 197 M | Nasdaq Capital Market | ||
|
The Cooper Companies
COO
|
$ 70.18 | -2.0 % | $ 14 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.38 | -1.85 % | $ 109 M | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 70.67 | 0.18 % | $ 4.18 B | Nasdaq Global Select Market,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Harvard Bioscience
HBIO
|
$ 5.73 | 16.7 % | $ 254 M | Nasdaq Global Market | ||
|
electroCore
ECOR
|
$ 6.68 | 1.98 % | $ 56.7 K | Nasdaq Global Select Market | ||
|
Glaukos Corporation
GKOS
|
$ 120.35 | -0.17 % | $ 5.83 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.69 | 0.03 % | $ 20.7 M | NYSE American | ||
|
Masimo Corporation
MASI
|
$ 178.41 | 0.01 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 125.72 | -1.67 % | $ 3.1 B | Nasdaq Global Select Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.28 | -5.48 % | $ 23 M | NYSE American | ||
|
InfuSystem Holdings
INFU
|
$ 10.21 | 2.2 % | $ 211 M | NYSE American | ||
|
STERIS plc
STE
|
$ 221.74 | -1.41 % | $ 21.9 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 126.03 | 0.61 % | $ 5.62 B | NYSE,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 27.08 | -1.11 % | $ 4.55 B | NYSE | ||
|
Utah Medical Products
UTMD
|
$ 69.01 | 0.94 % | $ 224 M | Nasdaq Global Select Market | ||
|
Pro-Dex
PDEX
|
$ 50.72 | -3.88 % | $ 167 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 468.53 | 0.28 % | $ 167 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 114.93 | -2.1 % | $ 2.6 B | Nasdaq Global Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 12.06 | -1.31 % | $ 2.4 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 21.21 | 4.44 % | $ 977 M | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 17.61 | 0.09 % | $ 9.03 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 228.69 | -0.86 % | $ 33.4 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 29.33 | -0.24 % | $ 1.4 B | Nasdaq Global Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 19.44 | -3.38 % | $ 1.31 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 2.0 | -1.72 % | $ 182 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 24.42 | -0.04 % | $ 1.21 B | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 265.67 | -0.86 % | $ 19.2 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 10.34 | -1.24 % | $ 422 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 155.51 | -0.12 % | $ 44.7 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.11 | 7.81 % | $ 32.3 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.24 | 0.78 % | $ 238 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 132.02 | 0.76 % | $ 7.36 M | Nasdaq Global Select Market,SPB |